1.Analgesic efficiency of dexketoprofen trometamol in third molar surgery: a systematic review and meta-analysis
Bishwa Prakash BHATTARAI ; Diane Isabel SELVIDO ; Dinesh ROKAYA
Journal of Dental Anesthesia and Pain Medicine 2024;24(5):305-318
This study aims to compare the analgesic efficacy of dexketoprofen trometamol (DT) with other analgesic drugs for pain relief after third molar surgery. The PubMed, Scopus, and Web of Science databases were searched to identify randomized controlled trials comparing DT with other analgesics for third molar surgery. The outcome measures were the sum of pain intensity differences (SPID), total pain relief (TOTPAR) at the 6th and 8thpostoperative hours, time to rescue medication, and tolerability. In total, four studies met our inclusion criteria.A total of 660 third molar surgeries were performed: 365 in the DT group and 295 in the active control group. Compared to other analgesics, DT produced significantly better pain relief at the 6th postoperative hour:SPID (MD, 0.33; P = 0.01) and TOTPAR (MD, 0.41; P = 0.02). However, there were no statistically significant differences in the efficiency of pain relief at the 8th postoperative hour, time to rescue medication, or tolerability.Overall, a 25 mg dose produced the best results for pain relief. In conclusion, DT (25 mg) is a viable alternative to contemporary analgesics for pain relief after third molar surgery, particularly during the early postoperative period.
2.Analgesic efficiency of dexketoprofen trometamol in third molar surgery: a systematic review and meta-analysis
Bishwa Prakash BHATTARAI ; Diane Isabel SELVIDO ; Dinesh ROKAYA
Journal of Dental Anesthesia and Pain Medicine 2024;24(5):305-318
This study aims to compare the analgesic efficacy of dexketoprofen trometamol (DT) with other analgesic drugs for pain relief after third molar surgery. The PubMed, Scopus, and Web of Science databases were searched to identify randomized controlled trials comparing DT with other analgesics for third molar surgery. The outcome measures were the sum of pain intensity differences (SPID), total pain relief (TOTPAR) at the 6th and 8thpostoperative hours, time to rescue medication, and tolerability. In total, four studies met our inclusion criteria.A total of 660 third molar surgeries were performed: 365 in the DT group and 295 in the active control group. Compared to other analgesics, DT produced significantly better pain relief at the 6th postoperative hour:SPID (MD, 0.33; P = 0.01) and TOTPAR (MD, 0.41; P = 0.02). However, there were no statistically significant differences in the efficiency of pain relief at the 8th postoperative hour, time to rescue medication, or tolerability.Overall, a 25 mg dose produced the best results for pain relief. In conclusion, DT (25 mg) is a viable alternative to contemporary analgesics for pain relief after third molar surgery, particularly during the early postoperative period.
3.Analgesic efficiency of dexketoprofen trometamol in third molar surgery: a systematic review and meta-analysis
Bishwa Prakash BHATTARAI ; Diane Isabel SELVIDO ; Dinesh ROKAYA
Journal of Dental Anesthesia and Pain Medicine 2024;24(5):305-318
This study aims to compare the analgesic efficacy of dexketoprofen trometamol (DT) with other analgesic drugs for pain relief after third molar surgery. The PubMed, Scopus, and Web of Science databases were searched to identify randomized controlled trials comparing DT with other analgesics for third molar surgery. The outcome measures were the sum of pain intensity differences (SPID), total pain relief (TOTPAR) at the 6th and 8thpostoperative hours, time to rescue medication, and tolerability. In total, four studies met our inclusion criteria.A total of 660 third molar surgeries were performed: 365 in the DT group and 295 in the active control group. Compared to other analgesics, DT produced significantly better pain relief at the 6th postoperative hour:SPID (MD, 0.33; P = 0.01) and TOTPAR (MD, 0.41; P = 0.02). However, there were no statistically significant differences in the efficiency of pain relief at the 8th postoperative hour, time to rescue medication, or tolerability.Overall, a 25 mg dose produced the best results for pain relief. In conclusion, DT (25 mg) is a viable alternative to contemporary analgesics for pain relief after third molar surgery, particularly during the early postoperative period.
4.Analgesic efficiency of dexketoprofen trometamol in third molar surgery: a systematic review and meta-analysis
Bishwa Prakash BHATTARAI ; Diane Isabel SELVIDO ; Dinesh ROKAYA
Journal of Dental Anesthesia and Pain Medicine 2024;24(5):305-318
This study aims to compare the analgesic efficacy of dexketoprofen trometamol (DT) with other analgesic drugs for pain relief after third molar surgery. The PubMed, Scopus, and Web of Science databases were searched to identify randomized controlled trials comparing DT with other analgesics for third molar surgery. The outcome measures were the sum of pain intensity differences (SPID), total pain relief (TOTPAR) at the 6th and 8thpostoperative hours, time to rescue medication, and tolerability. In total, four studies met our inclusion criteria.A total of 660 third molar surgeries were performed: 365 in the DT group and 295 in the active control group. Compared to other analgesics, DT produced significantly better pain relief at the 6th postoperative hour:SPID (MD, 0.33; P = 0.01) and TOTPAR (MD, 0.41; P = 0.02). However, there were no statistically significant differences in the efficiency of pain relief at the 8th postoperative hour, time to rescue medication, or tolerability.Overall, a 25 mg dose produced the best results for pain relief. In conclusion, DT (25 mg) is a viable alternative to contemporary analgesics for pain relief after third molar surgery, particularly during the early postoperative period.
5.An epidemiological study on the prevalence of temporomandibular disorder and associated history and problems in Nepalese subjects
Dinesh ROKAYA ; Kanokwan SUTTAGUL ; Shraddha JOSHI ; Bishwa Prakash BHATTARAI ; Pravin Kumar SHAH ; Shantanu DIXIT
Journal of Dental Anesthesia and Pain Medicine 2018;18(1):27-33
BACKGROUND: Temporomandibular disorder (TMD) represents a subgroup of painful orofacial disorders involving pain in the temporomandibular joint (TMJ) region, fatigue of the cranio-cervico-facial muscles (especially masticatory muscles), limitation of mandible movement, and the presence of a clicking sound in the TMJ. TMD is associated with multiple factors and systemic diseases. This study aimed to assess the prevalence of TMD in Nepalese subjects for the first time. METHODS: A total of 500 medical and dental students (127 men and 373 women) participated in this study from May 2016 to September 2016. The Fonseca questionnaire was used as a tool to evaluate the prevalence of TMD, and Fonseca's Anamnestic Index (FAI) was used to classify the severity of TMD. RESULTS: The majority of the participants with TMD had a history of head trauma, psychological stress, and dental treatment or dental problems. The prevalence of TMD in Nepalese students was mild to moderate. CONCLUSIONS: The prevalence of TMD in Nepalese subjects was mild to moderate. The majority of the study subjects had eyesight problems, history of head trauma, psychological stress, and drinking alcohol and had received dental treatments.
Craniocerebral Trauma
;
Dentistry
;
Drinking
;
Epidemiologic Studies
;
Fatigue
;
Humans
;
Male
;
Mandible
;
Muscles
;
Prevalence
;
Stress, Psychological
;
Students, Dental
;
Temporomandibular Joint
;
Temporomandibular Joint Disorders